Eugene T. Starr
Plus aucun poste en cours
Profil
Eugene T.
Starr served as President, Chief Executive Officer & Director of Vascular Pathways, Inc. and President & Chief Executive Officer of Venetec International, Inc. He also served as Director of Biomerge Industries Ltd.
and Director of Neovasc, Inc. from 2007 to 2008.
Prior to that, he was President of CONMED Corp.
and Group Vice President of United States Surgical Corp.
Starr's education includes an undergraduate degree from the University of Charleston.
Anciens postes connus de Eugene T. Starr
| Sociétés | Poste | Fin |
|---|---|---|
Biomerge Industries Ltd.
 Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Directeur/Membre du Conseil | 28/05/2009 |
| NEOVASC INC. | Directeur/Membre du Conseil | 01/07/2008 |
Vascular Pathways, Inc.
 Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | Directeur Général | - |
United States Surgical Corp.
 United States Surgical Corp. Medical SpecialtiesHealth Technology United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT. | Corporate Officer/Principal | - |
GVA Advantis
 GVA Advantis Real Estate DevelopmentFinance GVA Advantis provides real estate services. The private company is based in Atlanta, GA and has subsidiaries in United States. The CEO of the company is Petch Gibbons. | President | - |
Formation de Eugene T. Starr
| University of Charleston | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CONMED CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Venetec International, Inc.
 Venetec International, Inc. Medical DistributorsDistribution Services Venetec International, Inc. develops, manufactures and sells secure devices for medical catheters and tubes. It retains fast-track research & development capability while extending statLock product penetration to markets worldwide. The company was founded by Steven F. Bierman in 1996 and is headquartered in San Diego, CA. | Distribution Services |
GVA Advantis
GVA Advantis Real Estate DevelopmentFinance GVA Advantis provides real estate services. The private company is based in Atlanta, GA and has subsidiaries in United States. The CEO of the company is Petch Gibbons. | Finance |
United States Surgical Corp.
United States Surgical Corp. Medical SpecialtiesHealth Technology United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT. | Health Technology |
Biomerge Industries Ltd.
Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Health Technology |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
Vascular Pathways, Inc.
Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | Health Technology |
